Journal of International Oncology››2018,Vol. 45››Issue (3): 134-138.doi:10.3760/cma.j.issn.1673422X.2018.03.002
Previous ArticlesNext Articles
Ye Zhihua, Huang Geng, Fu Jinlun, Gui Dingwen
Received:
2017-09-11Online:
2018-03-08Published:
2018-05-16Contact:
Huang Geng E-mail:huanggsir@163.comYe Zhihua, Huang Geng, Fu Jinlun, Gui Dingwen. Effects of miR-1280 expression on the cell cycle and proliferation of bladder cancer by activating p21 gene expression[J]. Journal of International Oncology, 2018, 45(3): 134-138.
[1] Kluth LA, Black PC, Bochner BH, et al. Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature[J]. Eur Urol, 2015, 68(2): 238-253. DOI: 10.1016/j.eururo.2015.01.032. [2] Kim SW. The role of microRNAs in colorectal cancer[J]. Korean J Gastroenterol, 2017, 69(4): 206-211. DOI: 10.4166/kjg.2017.69.4.206. [3] Ramchandran R, ChaluvallyRaghavan P. miRNAmediated RNA activation in mammalian cells[J]. Adv Exp Med Biol, 2017, 983: 81-89. DOI: 10.1007/978-981-10-4310-9_6. [4] Huang B, Yang H, Cheng X, et al. tRF/miR1280 suppresses stem celllike cells and metastasis in colorectal cancer[J]. Cancer Res, 2017, 77(12): 3194-3206. DOI: 10.1158/0008-5472.CAN-16-3146. [5] Vanacore D, Boccellino M, Rossetti S, et al. Micrornas in prostate cancer: an overview[J]. Oncotarget, 2017, 8(30): 50240-50251. DOI: 10.18632/oncotarget.16933. [6] Sun V, Zhou WB, Nosrati M, et al. Antitumor activity of miR1280 in melanoma by regulation of Src[J]. Mol Ther, 2015, 23(1): 71-78. DOI: 10.1038/mt.2014.176. [7] Meng D, Li Z, Ma X, et al. MicroRNA1280 modulates cell growth and invasion of thyroid carcinoma through targeting estrogen receptor α[J]. Cell Mol Biol (Noisylegrand), 2016, 62(3): 1-6. [8] Kang MR, Li G, Pan T, et al. Development of therapeutic dsP21322 for cancer treatment[J]. Adv Exp Med Biol, 2017, 983: 217-229. DOI: 10.1007/978-981-10-4310-9_16. [9] Li S, Wang C, Yu X, et al. miR36195p inhibits prostate cancer cell growth by activating CDKN1A expression[J]. Oncol Rep, 2017, 37(1): 241-248. DOI: 10.3892/or.2016.5250. [10] Ge Q, Wang C, Chen Z, et al. The suppressive effects of miR11805p on the proliferation and tumorigenicity of bladder cancer cells[J]. Histol Histopathol, 2017, 32(1): 77-86. DOI: 10.14670/HH-11-772. [11] Yan J, Hao C, DeLucia M, et al. CyclinA2cyclindependent kinase regulates SAMHD1 protein phosphohydrolase domain[J]. J Biol Chem, 2015, 290(21): 13279-13292. DOI: 10.1074/jbc.M115.646588. [12] Zhao H, Zhang S, Xu D, et al. Expression of the p12 subunit of human DNA polymerase σ (Pol σ), CDK inhibitor p21(WAF1), Cdt1, cyclin A, PCNA and Ki-67 in relation to DNA replication in individual cells[J]. Cell Cycle, 2014, 13(22): 3529-3540. DOI: 10.4161/15384101.2014.958910. [13] Tang K, Wang C, Chen Z, et al. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer[J]. Int J Clin Exp Pathol, 2015, 8(5): 4999-5007. |
[1] | Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190. |
[2] | Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207. |
[3] | Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198. |
[4] | Jin Jiahui, Chen Cunhai, Ma Xuezhen.Effects of radiation-associated miRNA in radiotherapy for breast cancer[J]. Journal of International Oncology, 2022, 49(12): 735-738. |
[5] | Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer[J]. Journal of International Oncology, 2022, 49(11): 681-686. |
[6] | Xu Xi, Gao Hongliang, Liu Xiang, Zhang Zhensheng, Xu Chuanliang.Correlations between different pH values in tumor microenvironment and bladder cancer[J]. Journal of International Oncology, 2022, 49(11): 696-609. |
[7] | Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis[J]. Journal of International Oncology, 2022, 49(1): 45-50. |
[8] | Hong Anlan, Cao Meng, Wang Yan, Fang Fang.Research progress on lncRNAs as members of ceRNA network in melanoma[J]. Journal of International Oncology, 2022, 49(1): 61-64. |
[9] | Liu Pei, Pu Jiaze, Huang Wen, Wang Fei.Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis[J]. Journal of International Oncology, 2021, 48(7): 409-414. |
[10] | Wang Yang, Liu Qian, Long Hui, Wu Qingming.Research status of fecal detection for colorectal cancer markers[J]. Journal of International Oncology, 2021, 48(7): 441-444. |
[11] | Wang Ziyi, Chen Hongjie, Yang Ninggang, Zhang Jun, Zhang Xiangjun, Yu Xinning, Ma Zhongyi, Dai Enlai.Effects of decorin on proliferation, migration and invasion of bladder cancer cells[J]. Journal of International Oncology, 2021, 48(6): 335-340. |
[12] | Cheng Yiming, Li Gang, Wang Zhenming, Lyu Qianwen, Li Shirong.Value of serum miR-196a-5p and miR-105-5p in differential diagnosis of benign and malignant pulmonary nodules[J]. Journal of International Oncology, 2021, 48(5): 282-286. |
[13] | Deng Bo'er, Kong Weimin.Epigenetic research progress of endometrial cancer[J]. Journal of International Oncology, 2021, 48(3): 184-188. |
[14] | Li Bingliang, Yang Ya, Huang Yingli, Si Wen, Li Xingwei, Zhang Yuanmin, Bian Jichao, Chen Yu.Effects of miR-20a-5p targeting KDM6B on the proliferation, migration and invasion of osteosarcoma cells[J]. Journal of International Oncology, 2021, 48(2): 65-73. |
[15] | He Miao, Fan Kui, Cao Fang.Epigenetics and drug resistance in lung cancer[J]. Journal of International Oncology, 2021, 48(10): 622-626. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||